EE200400065A - Atasanaviiri kasutamine HIV-i ravis - Google Patents
Atasanaviiri kasutamine HIV-i ravisInfo
- Publication number
- EE200400065A EE200400065A EEP200400065A EEP200400065A EE200400065A EE 200400065 A EE200400065 A EE 200400065A EE P200400065 A EEP200400065 A EE P200400065A EE P200400065 A EEP200400065 A EE P200400065A EE 200400065 A EE200400065 A EE 200400065A
- Authority
- EE
- Estonia
- Prior art keywords
- hiv
- atazanavir
- protease inhibitor
- treatment
- triglyceride levels
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31674501P | 2001-08-31 | 2001-08-31 | |
| PCT/US2002/026675 WO2003020206A2 (en) | 2001-08-31 | 2002-08-21 | Use of atazanavir in hiv therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200400065A true EE200400065A (et) | 2004-06-15 |
Family
ID=23230468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200400065A EE200400065A (et) | 2001-08-31 | 2002-08-21 | Atasanaviiri kasutamine HIV-i ravis |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20030045501A1 (et) |
| EP (1) | EP1420799B1 (et) |
| JP (1) | JP2005501880A (et) |
| KR (1) | KR20040029447A (et) |
| CN (1) | CN1245988C (et) |
| AT (1) | ATE341332T1 (et) |
| AU (1) | AU2002332610B2 (et) |
| BG (1) | BG108585A (et) |
| BR (1) | BR0211544A (et) |
| CA (1) | CA2458807A1 (et) |
| CZ (1) | CZ2004288A3 (et) |
| DE (1) | DE60215189T2 (et) |
| DK (1) | DK1420799T3 (et) |
| EE (1) | EE200400065A (et) |
| ES (1) | ES2274119T3 (et) |
| HK (1) | HK1061640A1 (et) |
| HR (1) | HRP20040181A2 (et) |
| HU (1) | HUP0401091A2 (et) |
| IL (1) | IL159849A0 (et) |
| IS (1) | IS7158A (et) |
| MX (1) | MXPA04001721A (et) |
| NO (1) | NO20040803L (et) |
| NZ (1) | NZ530722A (et) |
| PL (1) | PL367873A1 (et) |
| RU (1) | RU2316341C2 (et) |
| WO (1) | WO2003020206A2 (et) |
| YU (1) | YU12204A (et) |
| ZA (1) | ZA200401412B (et) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE428411T1 (de) * | 2003-11-07 | 2009-05-15 | Jj Pharma Inc | Hdl-verstärkende kombinationstherapie-komplexe |
| US20050148523A1 (en) * | 2003-12-15 | 2005-07-07 | Colonno Richard J. | Method of treating HIV infection in atazanavir-resistant patients using a combination of atazanavir and another protease inhibitor |
| AR066972A1 (es) * | 2007-06-12 | 2009-09-23 | Concert Pharmaceuticals Inc | Derivados azapeptidicos |
| US20100183715A1 (en) * | 2007-06-22 | 2010-07-22 | Bristo-Meyers Squibb Company | Tableted compositions containing atazanavir |
| ES2359770T3 (es) * | 2007-06-22 | 2011-05-26 | Bristol-Myers Squibb Company | Composiciones en comprimidos que contienen atazanavir. |
| PT2178513E (pt) * | 2007-06-22 | 2011-05-31 | Bristol Myers Squibb Co | Composi??es em comprimido que cont?m atazanavir |
| ATE499927T1 (de) * | 2007-06-22 | 2011-03-15 | Bristol Myers Squibb Co | Tablettierte atazanavirhaltige zusammensetzungen |
| WO2009056818A1 (en) * | 2007-10-29 | 2009-05-07 | Cipla Limited | Novel antiretroviral combination |
| CN101249138B (zh) * | 2008-03-28 | 2012-03-21 | 中国人民解放军军事医学科学院野战输血研究所 | 一种含五味子乙醇提取物的抗艾滋病药物组合物 |
| BR112012024522A2 (pt) * | 2010-04-02 | 2017-08-08 | Phivco 1 Llc | combinação, uso de uma combinação, composição farmacêutica, forma de dosagem única , kit, e, método para tratar um distúrbio |
-
2002
- 2002-08-21 BR BR0211544-1A patent/BR0211544A/pt not_active IP Right Cessation
- 2002-08-21 WO PCT/US2002/026675 patent/WO2003020206A2/en active IP Right Grant
- 2002-08-21 HU HU0401091A patent/HUP0401091A2/hu unknown
- 2002-08-21 US US10/225,754 patent/US20030045501A1/en not_active Abandoned
- 2002-08-21 DK DK02797744T patent/DK1420799T3/da active
- 2002-08-21 AT AT02797744T patent/ATE341332T1/de not_active IP Right Cessation
- 2002-08-21 CN CNB028166868A patent/CN1245988C/zh not_active Expired - Fee Related
- 2002-08-21 NZ NZ530722A patent/NZ530722A/en unknown
- 2002-08-21 JP JP2003524520A patent/JP2005501880A/ja not_active Withdrawn
- 2002-08-21 RU RU2004106787/14A patent/RU2316341C2/ru not_active IP Right Cessation
- 2002-08-21 ES ES02797744T patent/ES2274119T3/es not_active Expired - Lifetime
- 2002-08-21 EP EP02797744A patent/EP1420799B1/en not_active Expired - Lifetime
- 2002-08-21 YU YU12204A patent/YU12204A/sh unknown
- 2002-08-21 AU AU2002332610A patent/AU2002332610B2/en not_active Ceased
- 2002-08-21 EE EEP200400065A patent/EE200400065A/et unknown
- 2002-08-21 CZ CZ2004288A patent/CZ2004288A3/cs unknown
- 2002-08-21 KR KR10-2004-7002851A patent/KR20040029447A/ko not_active Application Discontinuation
- 2002-08-21 PL PL02367873A patent/PL367873A1/xx not_active Application Discontinuation
- 2002-08-21 CA CA002458807A patent/CA2458807A1/en not_active Abandoned
- 2002-08-21 MX MXPA04001721A patent/MXPA04001721A/es active IP Right Grant
- 2002-08-21 IL IL15984902A patent/IL159849A0/xx unknown
- 2002-08-21 DE DE60215189T patent/DE60215189T2/de not_active Expired - Fee Related
-
2004
- 2004-02-17 BG BG108585A patent/BG108585A/bg unknown
- 2004-02-19 IS IS7158A patent/IS7158A/is unknown
- 2004-02-20 ZA ZA200401412A patent/ZA200401412B/en unknown
- 2004-02-23 HR HR20040181A patent/HRP20040181A2/xx not_active Application Discontinuation
- 2004-02-24 NO NO20040803A patent/NO20040803L/no not_active Application Discontinuation
- 2004-06-24 HK HK04104527A patent/HK1061640A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BG108585A (bg) | 2005-04-30 |
| CN1547476A (zh) | 2004-11-17 |
| HRP20040181A2 (en) | 2004-08-31 |
| DK1420799T3 (da) | 2007-01-15 |
| DE60215189D1 (de) | 2006-11-16 |
| WO2003020206A2 (en) | 2003-03-13 |
| IL159849A0 (en) | 2004-06-20 |
| CZ2004288A3 (cs) | 2004-12-15 |
| PL367873A1 (en) | 2005-03-07 |
| US20030045501A1 (en) | 2003-03-06 |
| NZ530722A (en) | 2007-11-30 |
| AU2002332610B2 (en) | 2007-11-08 |
| DE60215189T2 (de) | 2007-10-25 |
| EP1420799A2 (en) | 2004-05-26 |
| IS7158A (is) | 2004-02-19 |
| WO2003020206A3 (en) | 2003-10-02 |
| ATE341332T1 (de) | 2006-10-15 |
| RU2316341C2 (ru) | 2008-02-10 |
| MXPA04001721A (es) | 2004-05-31 |
| ZA200401412B (en) | 2005-03-18 |
| NO20040803L (no) | 2004-02-24 |
| HK1061640A1 (en) | 2004-09-30 |
| KR20040029447A (ko) | 2004-04-06 |
| BR0211544A (pt) | 2004-07-13 |
| EP1420799A4 (en) | 2004-11-24 |
| EP1420799B1 (en) | 2006-10-04 |
| CA2458807A1 (en) | 2003-03-13 |
| HUP0401091A2 (hu) | 2004-08-30 |
| CN1245988C (zh) | 2006-03-22 |
| YU12204A (sh) | 2006-08-17 |
| JP2005501880A (ja) | 2005-01-20 |
| ES2274119T3 (es) | 2007-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200400065A (et) | Atasanaviiri kasutamine HIV-i ravis | |
| ATE416789T1 (de) | Kombinationen für die hcv-behandlung | |
| RS51976B (en) | PYRFENIDONSKY THERAPY I INDUCATORS CITOHROMA P450 | |
| DK0871465T3 (da) | Anvendelse af ritonavir (ABT-538) til at forbedre farmakokinetikken af lægemidler, som metaboliseres af cytochrom P450, i en metode til behandling af AIDS | |
| DE60107065D1 (de) | Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut | |
| NO20053455L (no) | Anvendelse av en kombinasjon inneholdende en ikke-nukleosid revers transkriptase inhibitor (NNRTI) med en inhibitor av cytokrom P450 sa som protease inhibitorer | |
| AU2002302587A1 (en) | Acne treatment with lipooxigenase inhibitors | |
| MX2010002909A (es) | Metodo de tratamiento de pacientes de hepatitis c. | |
| WO2003024386A8 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis | |
| NO20090322L (no) | 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor | |
| MX2022014034A (es) | Métodos para tratar covid-19 con el uso de bardoxolona metilo o análogos de esta. | |
| MXPA05001885A (es) | El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica. | |
| RU2004106787A (ru) | Применение атазанавира в терапии вич-инфекции | |
| ZA991029B (en) | Composition and methods for treatment of hiv infections. | |
| EP1696918A4 (en) | METHOD FOR THE TREATMENT OF HIV INFECTIONS IN PATIENTS WITH ATAZANAVIR RESISTANCE USING A COMBINATION OF ATAZANAVIR AND ANOTHER PROTEASE INHIBITOR | |
| WO2022092907A3 (ko) | 다부위에 적용가능한 플라즈마 치료기 | |
| AU4111600A (en) | The use of gssg reductase for the therapy and prophylaxis of hiv infected patients | |
| DE602005023717D1 (de) | Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids-related complex (arc) | |
| AU2002317877A1 (en) | Use of a lactate salt for the treatment and prophylaxis of atherosclerosis | |
| MX2022011138A (es) | Efecto contra coronavirus y aplicacion de inhibidor de fosfatidilinositol 4-cinasa. | |
| MX2020005029A (es) | Metodos y composiciones para el mejoramiento de la funcion lisosomal y tratamiento de enfermedad neurodegenerativa. | |
| WO2023240199A3 (en) | Fitusiran for the treatment of hemophilia a and b | |
| UA28400A (uk) | Спосіб лікування мікробної екземи | |
| UA32184A (uk) | Суміш для лаважу інфікованого вогнища | |
| UA3215U (uk) | Спосіб лікування пацієнтів хворих фосааксиляріозом |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC1A | Change of owner name |